Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy

Chang Yun Yoon, Tae Ik Chang, Ea Wha Kang, Beom Jin Lim, Jeong Hae Kie, Youn Kyung Kee, Hyoungnae Kim, Seohyun Park, Hae Ryong Yun, Su Young Jung, Jong Hyun Jhee, Young Eun Kwon, Hyung Jung Oh, Jung Tak Park, Tae Hyun Yoo, Shin Wook Kang, Hyeon Joo Jeong, Seung Hyeok Han

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: The Oxford classification has been widely used in IgA nephropathy. However, its clinical usefulness of determining immunosuppression is unknown. Aim: Whether the Oxford classification could predict the development of proteinuria ≥1 g/g Cr and worsening kidney function, as well as the clinical efficacy of corticosteroid treatment according to each histologic variable of the Oxford-MEST. Methods: We included 377 patients with early-stage IgA nephropathy. The study endpoints were the development of a heavy proteinuria and a decline renal function. Results: The results showed that among the Oxford-MEST lesions, only M1 predicted the risk of the development of proteinuria ≥1.0 g/g Cr compared to other lesions in a time-varying Cox model adjusted for multiple confounding factors. In addition, the risk of reaching a 30% decline in eGFR was significantly higher in patients with M1 than in those with M0. Furthermore, patients with M1 had a greater decline of eGFR than patients with M0. However, steroid treatment in M1 lesion was not associated with improving clinical outcomes in the unmatched and propensity score matched cohort. Conclusions: This finding may provide a rationale for using the Oxford classification as a guidance to initiate immunosuppression in the early stages of IgA nephropathy.KEY MESSAGES M1 has independently predictive role among the Oxford lesions in IgA nephropathy. Oxford classification should be defined during pathologic approach. Decision of starting immunosuppression according to the Oxford lesions.

Original languageEnglish
Pages (from-to)217-229
Number of pages13
JournalAnnals of Medicine
Volume49
Issue number3
DOIs
Publication statusPublished - 2017 Apr 3

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy'. Together they form a unique fingerprint.

  • Cite this

    Yoon, C. Y., Chang, T. I., Kang, E. W., Lim, B. J., Kie, J. H., Kee, Y. K., Kim, H., Park, S., Yun, H. R., Jung, S. Y., Jhee, J. H., Kwon, Y. E., Oh, H. J., Park, J. T., Yoo, T. H., Kang, S. W., Jeong, H. J., & Han, S. H. (2017). Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy. Annals of Medicine, 49(3), 217-229. https://doi.org/10.1080/07853890.2016.1252058